88 Results for "

p75

" in MedChemExpress (MCE) Product Catalog:
Products (88)

88 Results for "p75" in MCE Product Catalog:

7
7 Publications Verification
Cat. No.: HY-110155
CAS No.: 1243259-19-9
Purity:  99.93%
Target:  

Neurotensin Receptor

Research Areas:  

Neurological Disease

LM11A-31 dihydrochloride, a non-peptide p75 NTR (neurotrophin receptor p75) modulator, is an orally active and potent proNGF (nerve growth factor) antagonist. LM11A-31 dihydrochloride is an amino acid derivative with high blood-brain barrier permeability and blocks p75-mediated cell death. LM11A-31 dihydrochloride reverses cholinergic neurite dystrophy in Alzheimer's disease mouse models with mid- to late-stage disease progression .
loading...
    loading...
7
7 Publications Verification
Cat. No.: HY-117088
CAS No.: 102562-74-3
Purity:  ≥95.0%
Target:  

Neurokinin Receptor

Research Areas:  

Neurological Disease

LM11A-31, a non-peptide p75 NTR (neurotrophin receptor p75) modulator, is an orally active and potent proNGF (nerve growth factor) antagonist. LM11A-31 is an amino acid derivative with high blood-brain barrier permeability and blocks p75-mediated cell death. LM11A-31 reverses cholinergic neurite dystrophy in Alzheimer's disease mouse models with mid- to late-stage disease progression .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-18601
CAS No.: 1416258-16-6
Target:  

HIV HIV Integrase

Research Areas:  

Infection

(±)-BI-D is a potent ALLINI (allosteric integrase inhibitor). (±)-BI-D binds integrase at the LEDGF/p75 binding site. (±)-BI-D inhibits HIV-Luc infection in cells (IC50: 0.16 μM in Psip1 knockout E9 mouse embryonic fibroblasts, 2.9 μM in wild-type E9 mouse embryonic fibroblasts) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-108466
CAS No.: 37854-59-4
Purity:  98.63%
Target:  

Apoptosis

Research Areas:  

Neurological Disease Cancer

Ro 08-2750 is a non-peptide and reversible nerve growth factor (NGF) inhibitor which binds to NGF, and with an IC50 of ~ 1 μM. Ro 08-2750 inhibits NGF binding to p75 NTR selectively over TRKA . Ro 08-2750 is a selective MSI RNA-binding activity inhibitor, with an IC50 of 2.7 μM .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-10522
CAS No.: 957890-42-5
Purity:  99.62%
Synonyms: CX05168; CX04328
Target:  

HIV HIV Integrase

Research Areas:  

Infection

LEDGIN6 (CX05168) is a quinoline-based protein-protein interaction inhibitor of LEDGF/p75 and HIV integrase .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-20878
CAS No.: 148741-30-4
Synonyms: AG 879
Research Areas:  

Cancer

Tyrphostin AG 879 (AG 879) is a tyrosine kinase inhibitor that inhibits TrKA phosphorylation (IC50 of 10 μM), but not TrKB and TrKC. Tyrphostin AG 879 is also a selective ErbB2 tyrosine kinase inhibitor with an IC50 of 1 μM, and has at least 500-fold higher selectivity to ErbB2 than EGFR. Tyrphostin AG 879 has anticancer activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-110166
CAS No.: 77422-99-2
Purity:  ≥99.0%
Target:  

Trk Receptor

Research Areas:  

Neurological Disease

PD 90780 is a non peptide antagonist of nerve growth factor (NGF). PD 90780 interacts with NGF, prevents NGF binds with p75 NTR. PD 90780 inhibits NGF-p75 NTR interaction with IC50s of 23.1 and 1.8 μM in PC12 cells and PC12 nnr5 cells, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99221
CAS No.: 880266-57-9
Synonyms: RN-624; PF 4383119
Tanezumab (RN-624) is a humanized anti-NGF mAb with high affinity and specificity. Tanezumab blocks NGF binding to its receptors, p75 and TrkA, in the peripheral nervous system. Tanezumab can be used in studies of acute and chronic pain such as osteoarthritis, knee and neuralgia, as well as post-herpetic neuralgia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-137322
CAS No.: 1372206-64-8
Purity:  99.84%
THX-B is a potent and non-peptidic p75 NTR (neurotrophin receptor p75) antagonist. THX-B can be used in the research of diabetic kidney disease, neurodegenerative and inflammatory disorders .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P72025
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Tumor necrosis factor receptor 2; TNF-R2; Tumor necrosis factor receptor type II; TNF-RII; TNFR-II; p75; p80 TNF-alpha receptor; CD120b; Etanercept; TBP-2; TBPII;
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P99297
CAS No.: 2171034-69-6
Synonyms: ZTS-00508841

Target:  

Trk Receptor

Research Areas:  

Inflammation/Immunology

Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) targeting nerve growth factor (NGF). Bedinvetmab inhibits NGF interaction with tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR) receptors. Bedinvetmab can be used for the research of osteoarthritis pain in dogs .
loading...
    loading...
Cat. No.: HY-130000
CAS No.: 2245231-10-9
Purity:  99.76%
Synonyms: STP0404
Target:  

HIV Integrase HIV

Research Areas:  

Infection

Pirmitegravir is a potent and first-in-class inhibitor of allosteric integrase (ALLINI) that targets LEDGF/p75 binding site. Pirmitegravir displays picomolar IC50 in human PBMCs with a >24,000 therapeutic index against HIV-1. Pirmitegravir harbors outstanding anti-virus and safety properties .
loading...
    loading...
Cat. No.: HY-111163
CAS No.: 908563-68-8
Purity:  98.74%
Target:  

Apoptosis

Research Areas:  

Cancer

NSC49652 is a reversible, orally active p75 neurotrophin receptor (p75 NTR, also known as NGFR, TNFRSF16, and CD271) agonist. NSC49652 targets the transmembrane domain of p75 NTR. NSC49652 induces apoptosis and affects the viability of melanoma cells .
loading...
    loading...
Cat. No.: HY-108935
CAS No.: 125697-91-8
Purity:  98.02%
Research Areas:  

Cancer

Lavendustin B is an inhibitor of HIV-1 integrase interaction with LEDGF/p75 with an IC50 of 94.07 μM. Lavendustin B is an ATP-competitive GLUT1 inhibitor with a Ki of 15 μM. Lavendustin B is also a weak inhibitor of tyrosine kinases .
loading...
    loading...
Cat. No.: HY-110155A
CAS No.: 1214672-15-7
Purity:  ≥98.0%
Target:  

Drug Isomer

Research Areas:  

Neurological Disease

(Rac)-LM11A-31 dihydrochloride is an isomer of LM11A-31 dihydrochloride. LM11A-31 dihydrochloride, a non-peptide p75 NTR (neurotrophin receptor p75) modulator, is an orally active and potent proNGF (nerve growth factor) antagonist .
loading...
    loading...
Cat. No.: HY-P990224

Research Areas:  

Infection Cancer

Anti-Mouse IL-12 p75 Antibody (R2-9A5) is a rat-derived IgG2b κ type antibody inhibitor, targeting to mouse IL-12 p75. Anti-Mouse IL-12 p75 Antibody (R2-9A5) can neutralize IL-12. Anti-Mouse IL-12 p75 Antibody (R2-9A5) can be used for the researches of infection and cancer, such as E. coli infection and MCA205 sarcoma .
loading...
    loading...
Cat. No.: HY-147653
CAS No.: 1431738-14-5
Target:  

HIV Integrase

Research Areas:  

Infection

Integrase-LEDGF/p75 allosteric inhibitor 1 (Compound 31h) is an orally active integrase-LEDGF/p75 (IN-LEDGF/p75) allosteric inhibitor. Integrase-LEDGF/p75 allosteric inhibitor 1 inhibits HIV-1 DNA integration and shows antiviral activity with an EC50 of 3.9 nM against HIV-1 recombinant molecular clone NL432 .
loading...
    loading...
Cat. No.: HY-153094
CAS No.: 1643876-33-8
Purity:  99.09%
Target:  

HIV HIV Integrase

Research Areas:  

Infection

BDM-2 is an IN-LEDGF allosteric inhibitor (INLAI) of HIV-1 integrase (IN refers to integrase) (IC50=47 nM) with potent anti-Retroviral (ARV) activity. BDM-2 shows IN multimerization activation effect with an AC50 value of 20 nM. BDM-2 blocks the interaction between the catalytic core domain of IN (IN-CCD) and the Integrase binding domain of LEDGF/p75 (IBD), with an IC50 value of 0.15 μM. BDM-2 exhibits highly selective and favorable cytotoxicity .
loading...
    loading...
Cat. No.: HY-124637
CAS No.: 234779-34-1
Purity:  98.24%
Target:  

Trk Receptor

Research Areas:  

Neurological Disease

ALE-0540, a nonpeptidic small molecule, is a nerve growth factor receptor antagonist. ALE-0540 inhibits the binding of NGF to tyrosine kinase (Trk) A or both p75 and TrkA with IC50 values of 5.88 μM and 3.72 μM, respectively. ALE-0540 can be used to examine mechanisms leading to the development of agents for the study of pain .
loading...
    loading...
Cat. No.: HY-18666
CAS No.: 497836-10-9
Target:  

HIV

Research Areas:  

Infection

D77 is anti-HIV-1 inhibitor targeting the interaction between integrase and cellular LEDGF/p75. D77 inhibits HIV-1(IIIB) replication by EC50 value of 23.8 μg/ml in MT-4 cell (5.03 μg/ml for C8166 cells).
loading...
    loading...